FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Sanofi, Elan rise on M&A talk

Tools

Sanofi-Aventis and Elan saw their stocks leap yesterday on deal rumors: Speculation that Sanofi may buy Merck's interest in its animal-health joint venture Merial sent its shares flying, while rumors that Pfizer might buy Elan boosted the Irish company's stock. Report | Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Elan   Sanofi-Aventis   Mergers and Acquisitions   asset sale